UM DERIVADO DE 4-(3-PIRAZOLILAMINO)-BENZIMIDAZOL COMO INIBIDOR DE JAK1 PARA O TRATAMENTO DE CANCRO

• 收藏
• 分享

专利权人:

ELI LILLY AND COMPANY

发明人:

JOSHUA RYAN CLAYTON

申请号：

PT16750326

公开号：

PT3331873T

申请日:

2016.07.28

申请国别(地区):

PT

年份:

2019

代理人:

摘要：

The present invention relates to certain benzimidazole compounds, or pharmaceutically acceptable salts thereof, that inhibit Janus kinase 1 (JAK1), pharmaceutical compositions comprising the compounds, and methods of using the compounds to treat certain types of cancer.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/